Related Experiment Videos
Endobronchial irradiation for malignant airway obstruction
M P Mehta1, S Shahabi, N N Jarjour
1Department of Human Oncology, University of Wisconsin Clinical Cancer Center, Madison 53792.
International Journal of Radiation Oncology, Biology, Physics
|October 1, 1989
Summary
This study shows that endobronchial irradiation (EBRT) using Iridium-192 is a safe and effective treatment for malignant airway obstruction, significantly improving symptoms and radiographic response in lung cancer patients.
Area of Science:
- Oncology
- Radiation Oncology
- Pulmonology
Background:
- Malignant airway obstruction significantly impacts patient quality of life and survival.
- Palliative treatment options are crucial for managing advanced lung cancer complications.
Purpose of the Study:
- To evaluate the safety and efficacy of an afterloading endobronchial irradiation (EBRT) technique using Iridium-192 (Ir-192) for malignant airway obstruction.
Main Methods:
- EBRT was performed under bronchoscopic guidance with catheter placement distal to the obstruction.
- Dosimetry was determined using orthogonal radiographs and CT scans.
- Forty implants were delivered to 38 patients, many with prior treatments.
Main Results:
- The procedure was well-tolerated with a low complication rate (10.5%).
- Seventy percent of patients experienced symptom relief or improvement.
- A 70% radiographic response was observed, with 12 of 14 patients showing complete response on post-treatment bronchoscopy.
Conclusions:
- Endobronchial irradiation (EBRT) is a safe and effective palliative technique for malignant airway obstruction.
- The Ir-192 EBRT technique offers significant symptom palliation and radiographic improvement.
- This approach demonstrates potential for improving quality of life in patients with advanced lung cancer.